当前位置：首页 > 文献互助 > 互助详情

Clinical outcomes of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and anti‐PD‐1 immunotherapy for unresectable intrahepatic cholangiocarcinoma复制

用户odusrbT5lLew 36分钟前 12 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-09-30 20:20:48 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: DOI: 10.1111/1751-2980.13127复制

文献链接: https://onlinelibrary.wiley.com/doi/10.1111/1751-2980.13127复制

其他信息:

出版社: Wiley
作者: Ning Zhang; Bing Ran Yu; Yi Xiu Wang; Yi Ming Zhao; Jia Min Zhou; Miao Wang; Long Rong Wang; Zhen Hai Lin; Ti Zhang; Lu Wang
全文下载地址: https://onlinelibrary.wiley.com/doi/pdf/10.1111/1751-2980.13127

上一篇：Hepatic Artery Infusion Chemotherapy as a First‐Line Treatment in Unresectable Cholangiocarcinoma: A Systematic Review and Meta‐Analysis

下一篇：Convergence of Local and Systemic Therapies: A Comprehensive Society of Interventional Oncology Framework for 90 Y Radioembolization with Immunotherapy in HCC

互助时间线

2026-09-23 20:21:15 [完结求助]

楼主确认了皮一下很开心应助的文件是正确的, 求助状态变成 已完结

2026-09-23 20:20:48 [上传文件]

皮一下很开心上传了文件(pdf 1.53 MB), 求助状态变成 待确认

2026-09-23 20:20:44 [发起求助]

最新发布的求助

Multiomics Integration Identifies a Molecular Subtype of Intrahepatic Cholangiocarcinoma With Enhanced Benefit From Adjuvant Therapy 10分钟前
Multiomics Integration Identifies a Molecular Subtype of Intrahepatic Cholangiocarcinoma With Enhanced Benefit From Adjuvant Therapy 11分钟前
Integrative multi-omics identifies cholangiolocarcinoma as a distinct molecular subtype of intrahepatic cholangiocarcinoma 14分钟前
Futibatinib after non-covalent FGFR inhibitors in FGFR2-rearranged intrahepatic cholangiocarcinoma: clinical activity and resistance patterns 17分钟前
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study 24分钟前
Tegileridine vs . sufentanil for postoperative analgesia in general surgery: A prospective, randomized, controlled, non‐inferiority trial. 26分钟前
Convergence of Local and Systemic Therapies: A Comprehensive Society of Interventional Oncology Framework for 90 Y Radioembolization with Immunotherapy in HCC 29分钟前
Clinical outcomes of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and anti‐PD‐1 immunotherapy for unresectable intrahepatic cholangiocarcinoma 36分钟前
Hepatic Artery Infusion Chemotherapy as a First‐Line Treatment in Unresectable Cholangiocarcinoma: A Systematic Review and Meta‐Analysis 43分钟前
FOLFOX-HAIC versus first-line systemic chemotherapy in HBsAg-positive patients with unresectable intrahepatic cholangiocarcinoma: A propensity score matched cohort study 2小时前
Transarterial Yttrium-90 Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis 2小时前
Comparison of efficacy and safety of conventional transarterial chemoembolization and drug-eluting bead transarterial chemoembolization in unresectable intrahepatic cholangiocarcinoma: A multicenter retrospective cohort study 2小时前

wispass工作室 Copyright © 蜀ICP备20005939号-4 www.wispass.com